Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004508

SVP, CHIEF LEGAL OFFICER gave up 11,955 shares (to pay taxes)

  • SVP, CHIEF LEGAL OFFICER acquired 22,205 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-16 Option exercise +17,409 32,411 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-16 Shares withheld for taxes −9,373 $58.29 $546,352 23,038 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-16 Option exercise +4,796 27,834 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-16 Shares withheld for taxes −2,582 $58.29 $150,505 25,252 D
Derivatives
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-16 Option exercise · Performance Stock Units −17,409 0 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-16 Option exercise · Restricted Stock Units −4,796 9,592 D
Loading xslF345X05/form4-02182025_110258.xml…